MX366113B - Metodos de diganostico y composiciones. - Google Patents

Metodos de diganostico y composiciones.

Info

Publication number
MX366113B
MX366113B MX2017003475A MX2017003475A MX366113B MX 366113 B MX366113 B MX 366113B MX 2017003475 A MX2017003475 A MX 2017003475A MX 2017003475 A MX2017003475 A MX 2017003475A MX 366113 B MX366113 B MX 366113B
Authority
MX
Mexico
Prior art keywords
compositions
diagnostic methods
methods
thermocycling
primers
Prior art date
Application number
MX2017003475A
Other languages
English (en)
Spanish (es)
Other versions
MX2017003475A (es
Inventor
Tabakman Scott
Lee Josephine
Belhocine Kamila
Richardson Aaron
Wu Indira
Patel Pranav
Original Assignee
Theranos Ip Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2014/056151 external-priority patent/WO2015076919A1/en
Application filed by Theranos Ip Co Llc filed Critical Theranos Ip Co Llc
Publication of MX2017003475A publication Critical patent/MX2017003475A/es
Publication of MX366113B publication Critical patent/MX366113B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/706Specific hybridization probes for hepatitis
    • C12Q1/707Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00Apparatus for enzymology or microbiology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6858Allele-specific amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/706Specific hybridization probes for hepatitis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Sustainable Development (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
MX2017003475A 2014-09-17 2015-09-17 Metodos de diganostico y composiciones. MX366113B (es)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201462051945P 2014-09-17 2014-09-17
US201462051912P 2014-09-17 2014-09-17
PCT/US2014/056151 WO2015076919A1 (en) 2013-11-22 2014-09-17 Nucleic Acid Amplification
US201462068605P 2014-10-24 2014-10-24
US201462068603P 2014-10-24 2014-10-24
US201562151358P 2015-04-22 2015-04-22
PCT/US2015/050811 WO2016044664A1 (en) 2014-09-17 2015-09-17 Diagnostic methods and compositions

Publications (2)

Publication Number Publication Date
MX2017003475A MX2017003475A (es) 2017-08-02
MX366113B true MX366113B (es) 2019-06-26

Family

ID=55533878

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017003475A MX366113B (es) 2014-09-17 2015-09-17 Metodos de diganostico y composiciones.
MX2017003473A MX2017003473A (es) 2014-09-17 2015-09-17 Amplificacion hibrida de acido nucleico en multiples pasos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2017003473A MX2017003473A (es) 2014-09-17 2015-09-17 Amplificacion hibrida de acido nucleico en multiples pasos.

Country Status (8)

Country Link
US (3) US9909193B2 (OSRAM)
EP (2) EP3194629A4 (OSRAM)
JP (6) JP2017532030A (OSRAM)
CN (3) CN113736863A (OSRAM)
BR (1) BR112017005392A2 (OSRAM)
CA (2) CA2961209A1 (OSRAM)
MX (2) MX366113B (OSRAM)
WO (2) WO2016044673A1 (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2961209A1 (en) 2014-09-17 2016-03-24 Theranos, Inc. Diagnostic methods and compositions
US10822648B1 (en) 2016-07-29 2020-11-03 Labrador Diagnostics Llc Hybrid multi-step nucleic acid amplification
CN110462042B (zh) 2016-12-15 2023-10-27 梅哈里医学院 抗病毒剂
FI130673B1 (en) * 2020-11-24 2024-01-11 Mobidiag Oy Method and system for performing a cumulative nucleic acid amplification reaction

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
EP0912761A4 (en) * 1996-05-29 2004-06-09 Cornell Res Foundation Inc DETERMINATION OF DIFFERENCES IN THE NUCLEIC ACID SEQUENCE BY MEANS OF A COMBINATION OF LIGASE DETERMINATION AND POLYMERASE CHAIN REACTION
US6743605B1 (en) * 1998-06-24 2004-06-01 Enzo Life Sciences, Inc. Linear amplification of specific nucleic acid sequences
AU2001244677A1 (en) * 2000-04-07 2001-10-23 Eiken Kagaku Kabushiki Kaisha Method of amplifying nucleic acid by using double-stranded nucleic acid as template
US6605451B1 (en) * 2000-06-06 2003-08-12 Xtrana, Inc. Methods and devices for multiplexing amplification reactions
US7041447B2 (en) * 2001-04-09 2006-05-09 St. Jude Children's Hospital, Inc. Haplotyping method for multiple distal nucleotide polymorphisms
EP1319718A1 (en) * 2001-12-14 2003-06-18 Keygene N.V. High throughput analysis and detection of multiple target sequences
WO2005014810A1 (ja) * 2003-08-08 2005-02-17 National Institute Of Advanced Industrial Science And Technology ダンベル型dnaの効率的な製造方法
JP4379087B2 (ja) * 2003-11-07 2009-12-09 トヨタ自動車株式会社 ゲラニルゲラニル二リン酸合成酵素及びゲラニルゲラニオールの製造方法
US20100075384A1 (en) * 2004-03-25 2010-03-25 New England Biolabs, Inc. Helicase-dependent amplification of circular nucleic acids
WO2006003721A1 (en) * 2004-07-02 2006-01-12 Kabushiki Kaisha Dnaform Method for preparing sequence tags
EP2458011B1 (en) * 2005-10-03 2013-07-24 Life Technologies Corporation Compositions, methods, and kits for amplifying nucleic acids
EP2162555A4 (en) * 2007-06-22 2011-02-23 Univ Columbia SPECIFIC AMPLIFICATION OF TUMOR-SPECIFIC DNA SEQUENCES
MX352987B (es) 2007-10-02 2017-12-15 Theranos Ip Co Llc Dispositivos modulares de punto de cuidado y usos de los mismos.
WO2010127020A1 (en) * 2009-04-29 2010-11-04 Js Genetics Inc. Molecular diagnosis of fragile x syndrome associated with fmr1 gene
IT1394539B1 (it) * 2009-05-19 2012-07-05 Sentinel Ch S P A Uso di uno stabilizzante delle polimerasi per la liofilizzazione e la preparazione di kit pronti per l'uso
WO2012038049A2 (en) * 2010-09-22 2012-03-29 Roche Diagnostics Gmbh Amplification of distant nucleic acid targets using engineered primers
CN102242211A (zh) * 2011-07-08 2011-11-16 无锡锐奇基因生物科技有限公司 检测突变核酸序列的方法及试剂盒
US8380541B1 (en) 2011-09-25 2013-02-19 Theranos, Inc. Systems and methods for collecting and transmitting assay results
US9632102B2 (en) 2011-09-25 2017-04-25 Theranos, Inc. Systems and methods for multi-purpose analysis
US9619627B2 (en) 2011-09-25 2017-04-11 Theranos, Inc. Systems and methods for collecting and transmitting assay results
US8435738B2 (en) 2011-09-25 2013-05-07 Theranos, Inc. Systems and methods for multi-analysis
US9250229B2 (en) 2011-09-25 2016-02-02 Theranos, Inc. Systems and methods for multi-analysis
CN108490204A (zh) 2011-09-25 2018-09-04 赛拉诺斯知识产权有限责任公司 用于多重分析的系统和方法
US9809845B2 (en) * 2012-08-06 2017-11-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods and reagents for amplifying nucleic acids
JP2014140367A (ja) * 2012-12-27 2014-08-07 Tosoh Corp B型肝炎ウイルスdna増幅用プライマーおよびそれを用いたb型肝炎ウイルスdna検出法
SG11201507272RA (en) 2013-03-15 2015-10-29 Theranos Inc Nuclei acid amplification
US9217167B2 (en) * 2013-07-26 2015-12-22 General Electric Company Ligase-assisted nucleic acid circularization and amplification
MX370616B (es) * 2013-11-22 2019-12-17 Theranos Ip Co Llc Amplificacion de acidos nucleicos.
CA2961209A1 (en) 2014-09-17 2016-03-24 Theranos, Inc. Diagnostic methods and compositions

Also Published As

Publication number Publication date
BR112017005392A2 (pt) 2017-12-12
JP2023011943A (ja) 2023-01-24
CA2960859A1 (en) 2016-03-24
US9909193B2 (en) 2018-03-06
WO2016044664A1 (en) 2016-03-24
US20180223381A1 (en) 2018-08-09
CN108026591A (zh) 2018-05-11
CA2961209A1 (en) 2016-03-24
JP2017531424A (ja) 2017-10-26
EP3194629A1 (en) 2017-07-26
MX2017003475A (es) 2017-08-02
MX2017003473A (es) 2017-08-02
EP3194590A4 (en) 2018-05-09
CN107002066A (zh) 2017-08-01
CN108026591B (zh) 2021-09-07
US20170342476A1 (en) 2017-11-30
JP2021006056A (ja) 2021-01-21
CN113736863A (zh) 2021-12-03
JP2017532030A (ja) 2017-11-02
US20160201148A1 (en) 2016-07-14
JP2021000138A (ja) 2021-01-07
EP3194590A1 (en) 2017-07-26
WO2016044673A1 (en) 2016-03-24
JP2022110152A (ja) 2022-07-28
EP3194629A4 (en) 2018-03-07

Similar Documents

Publication Publication Date Title
MX2015011435A (es) Amplificación de ácidos nucléicos.
EP3169793A4 (en) Isothermal methods for amplifying nucleic acid samples
SG10202108763UA (en) Methods and compositions for nucleic acid analysis
EP3294448A4 (en) Rapid methods for the extraction of nucleic acids from biological samples
WO2015196128A3 (en) Alternative nucleic acid molecules and uses thereof
WO2015196130A3 (en) Alternative nucleic acid molecules and uses thereof
GB2550745A (en) Crispr hybrid DNA/RNA Polynucleotides and methods of use
HK1257295A1 (zh) 用於免疫肿瘤学的组合物和方法
MX2017013878A (es) Amplificación de discordancias optimizadas multiplicadas (moma) - reacción en cadena de polimerasa (pcr) en tiempo real, para evaluar el ácido desoxirribonucleico (adn) libre de celula.
EP3234200A4 (en) Compositions and methods for targeted depletion, enrichment, and partitioning of nucleic acids using crispr/cas system proteins
EP3161162A4 (en) Analysis of nucleic acid sequences
WO2015161054A3 (en) Methods and systems for nucleic acid amplification
EP3541945A4 (en) COMPOSITIONS AND METHODS OF MODIFICATION OF TARGET NUCLEIC ACIDS
MX376755B (es) Detección de ácidos nucleicos diana mediante el uso de hibridación.
IL262019A (en) Nucleic acid stabilizing reagent, kits and methods for its use
GB201407334D0 (en) Integrated nucleic acid test system, instrument and method
EA038921B9 (ru) Обнаружение целевой нуклеиновой кислоты и ее вариантов
EP3134551A4 (en) Compositions and methods for enhancing and/or predicting dna amplification
EP3795681A3 (en) Polymerase compositions and methods of making and using same
IL260122A (en) Methods and compositions for assembly of nucleic acids
EP3143140A4 (en) Compositions and methods for single-molecule construction of dna
EP3209675A4 (en) Compositions and methods for the detection of nucleic acids
GB201604876D0 (en) Marine DNA polymerases
WO2015176006A3 (en) Genetic detection platform
MX2017003475A (es) Metodos de diganostico y composiciones.

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: THERANOS IP COMPANY, LLC

FG Grant or registration